Українська Русский English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2010; 56(5): 106-114


The glycosaminoglycans role inpathogenesis of atherosclerosis

O.I. Sukmansky, M.S. Drogomiretska,O.V. Den’ga, I.O. Sukmansky.

    Odesa State Agrarian University;P.L.Shupik National Medical Academy of Post-graduateEducation, Kyiv;Institute of Stomatology AMS of Ukraine, Odesa


Abstract

In this review we summarize the role of glycosaminoglycans and proteoglycans in pathogenesis of atherosclerosis and possibilities for correction of lesions of atherosclerotic vessels via influence on their metabolism.

Keywords: glycosaminoglycans, proteoglycans, athero-sclerosis, arterial wall

References

  1. Березовський В.Я., Літовка І.Г., Костюченко О.С. Фізіологічна регенерація кісткової тканини за умов дозованої нормобаричної гіпоксії // Фізіол. журн. -2007. - 57,№6. -С.40-45.
  2. Бойко Е. P., Канева A.M. Апопротен Е и его значение в клинической физиологии// Успехи физиол. наук. -2009. - 40,№1. -С.3-15.
  3. Горохивский В.Н., Подорожная Р.П., Сукманский О.И., Деньга О.В., Кнава О.Э., Макаренко О.А. Нарушения синтеза гликозаминогликанов при экспериментальном флюорозе и пути их коррекции/ /Рос. стоматол. журн. - 2008, № 1. –С.11-13.
  4. Дильман В.М. Старение, климакс и рак. -Л., 1968. - 130 с.
  5. Дрогомирецкая М.С., Сукманский О.И., Деньга О.В., Макаренко О.А., Подорожная Р.П., Кнава О.Э. Обмен гликозаминогликанов (ГАГ) в тканях полости рта и некоторых внутренних органах при экспери­ментальном атеросклерозе и его лечении на фоне ортодонтического вмешательства//Вiсн. стома­тології. - 2007. - №3. - C.11-16.
  6. Дрогомирецкая М.С., Сукманский О.И., Деньга О.В. Подорожная Р.П., Кнава О.Э. Обмен серосодер­жащих соединений при экспериментальном атеро­склерозе/ЯП Міжнар. наук. конф. ”Гомеостаз, фізіологія, патология, фармакологія і клініка”: Тези доп., Одеса, 2007. -С.39-40.
  7. Євдокімова Н.Ю. Гіалуронова кислота, рецептор CD44 та їхня роль в ускладненнях цукрового діабету//Укр.біохім. журн. - 2008. - 80, № 5. -С.5-44.
  8. Красникова Т.Л., Арефьева Т.П., Кухтина Н.Б. Хемокины, рецепторы хемокинов и атерогенез// Успехи соврем. биологии. - 2003. - 123,№5. -С.506-514.
  9. 9. Нагорнев В.А., Восканьянц А.Н. Атерогенез как иммуно-воспалительный процесс// Вести. РАМН. -2004. -№7. -С.3-11.
  10. 10. Сидоренко Б.А., Заикина Н.В., Преображенский Д.В. Эноксапарин и другие низкомолекулярные гепарины в кардиологии//Кардиология. - 1998. -№10. -С.82-90.
  11. Сидоренко Б.А., Преображенский Д.В. Низко­молекулярные гепарины: возможность применения// Тамже. - 1995. -№10. -С.86-91.
  12. Стойка Р.С., Фильченков А.А., Залесский В.Н. Цитокины и клетки-мишени в регуляторной системе атерогенеза//Успехи соврем.биологии. - 2003. - 123,№1. -С.82-97.
  13. Суданський О.І. Цитокіни - нова система біорегу-ляторів //Вісн. стоматології. - 2005. -№3. -С.69-74.
  14. Сукманський О.І., Горохівський В.Н. Глікоза-міноглікани (ГАГ) і кісткова тканина//Там само. -2009. -№3. -С.113-118.
  15. Цурко В.В., Леоненко И.В., Егоров И.В., Красно­сельский М.Я. Роль медиаторных механизмов в иммунопатогенезе воспаления при сердечно­сосудистых заболеваниях и остеопорозе//Терап. архив. - 2009. - 81, № 6. - С. - 92-96.
  16. Allain F., Vanpouille C., Carpentier M. Slomianny M.C., Durieux S., Spik G. Interaction with glycosami-noglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T-lymphocytes to extracellular matrix// Proc. Nat. Acad. Sci. USA. - 2002. - 99, №5. - P.2714-2719.
  17. Bot P.T., Hoefer I.E., Piek J.J., Pasterkamp G. Hyaluronic acid: targeting immune modulatory components of the extracellur matrix in atherosclero-sis//Curr. Med. Chem. - 2008. - 5. -№8. - P.786-791.
  18. Chai S., Chai Q., Danielsen C.C., Hjorth P., Nyengaard J.R., Ledet T., Yamaguchi Y., Rasmussen L.M., Wogensen L. Overexpression of hyaluronan in the tu­nica media promotes the development of atherosclero-sis//Circulat. Res. - 2005. - 96. - № 5. - P.583-591.
  19. 19. Dadlani H., Ballinger M.L., Osman N., Getachew R., Little P.J. Smad and p38 MAP kinase-mediated signaling of proteoglycan synthesis in vascular smooth muscle//J. Biol. Chem. - 2008. - 283. - № 12. - P.7844-7852.
  20. 20. Deepa P .R., Varalakshmi P. Atheroprotective effect of exogenous heparin-derivative treatment on the aortic disturbances and lipoprotein oxidation in hypercho-lesterolemic diet fed rats//Clin. Chim. Acta. - 2005. -355,№1-2. - P.l19-130.
  21. Deepa PR., Varalakshmi P. Favourable modulation of the inflammatory changes in hypercholesterolemic athero-genesis by a low-molecular-weight heparin derivative// Int. J. Cardiol. - 2006. - 106, №3. - P.338-347.
  22. Delmolino L.M., Stearns N.A, Castellot Jr. J.J. COP-l, a member of the CCN family, is a heparin-induced growth arrest specific gene in vascular smooth muscle cells//J. Cell Physiol. - 200I. - 188, № 1. - P.45-55.
  23. De Lorenzo F., Dotsenko O., Kakkar YY. Low molecular weight heparins in cardiovascular medicine// Minerva Cardioangiol. - 2005. - 53, № 6. - P.585-603.
  24. Duan Y, Paka L., Pillarisetti S. Distinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: evidence for a protective role for glucosamine in atherosclerosis//Cardiovasc. Diabetol. - 2005. - 4. - P. 16.
  25. Elhadj S., Mousa S.A., Forsten-Williams K. Chronic pulsatile shear stress impact synthesis of proteo­glycans by endothelial cells effect on platelet aggrega­tion and coagulationJ/J. Cell Biochem. - 2002. - 86, №2. - P.239-250.
  26. Fischer J. W., Schrnr K. Regulation of hyaluronan syn­thesis by vasodilatory prostaglandins. Implications for atherosclerosis//Throm. Haemost. - 2007. - 98, №2. -P.287-295.
  27. Gounffic Y, Guilluy C, Guйrin P., Patra P., Pacaud P., Loirand G. Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-de-pendent Rac activation//Cardiovasc. Res. - 2006. - 72, №2. - P.339-348.
  28. Hamati H.F., Britton E.L., Carey D.J. Inhibition of proteoglycan synthesis alters extracellular matrix depo­sition, proliferation, and cytoskeletal organization of rat aortic smooth muscle cells in culture//J. Cell Biol. -1989. - 108,№6. -P.2495-2505.
  29. 29. Herrero-Beaumont G., Marcos M.E., S6nchez-Pernaute O., Granados R., Ortega L., Montell E., Vergfis J., Egido J. Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis//Brit. J. Pharmacol. - 2008. - 154, №4. - P.843-851.
  30. 30. Iwasaki S., Minamisawa S., Yokoyama U., Akaike T., Quan H., Nagashima Y, Nishimaki S., Ishikawa Y Interleukin-15 inhibits smooth muscle cell prolifera­tion and hyaluronan production in rat ductus arteriosus/ / Pediatr. Res. - 2007. - 62, №4. - P.392-398.
  31. Kumar v., Cotran R.S., Robbins S.L. Robbins Basic Pathology. 7th ed. Philadelphia, London, Toronto etc.: W.B. Saunders Company, 2003. - 873 p.
  32. Lake A.C., Bialik A., Walsh K., Castellot J.J. CCN5 is a growth arrest-specific gene that regulates smooth muscle cell proliferation and motility// Amer. J. Pathol. -2003. -162, №1. -P.219-231.
  33. Lee M., Sommerhoff C.P., von Eckardstein A., Zettl F., Fritz H., Kovanen P.T. Mast cell tryptase degrades HDL and blocks its function as an acceptor of cellular cholesterol// Arterioscler. Thromb. Vasc. Biol. - 2002. -22,№12. -P.2086-2091.
  34. Libeu C.P, Lund-Katz S., Phillips M.C., Wehrli S., Hernaiz M.J., Capila I., Linhardt R.J., Raffai R.L., Newhouse YM. New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E//J. Biol. Chem. - 2001. - 276, №42. - P.39138-39144.
  35. Little. P.J., Ballinger M.L., Burch M.L., Osman N. Biosynthesis of natural and hyperelongated chondroi­tin sulfate glycoaminoglycans: new insights into an elusive process// Open Biochem. J. - 2008. - 2. - P.135-142.
  36. McDonald Т.О., Gerrity R.G., Jen C, Chen H.J., Wark K., Wight T.N., Chait A., O’Brien K.D. Diabetes and arterial extracellular matrix changes in a porcine model of atherosclerosis// J. Histochem. Cytochem. - 2007. -55, №11. -P.1149-1157.
  37. Mahley R.W., Huang Y. Atherogenic remnant lipoproteins: role for proteoglycans in trapping, trans­ferring, and internalizing//J. Clin. Invest. - 2007. - 117, №1. - P.94-98, 153-174.
  38. Marks D.B. Biochemistry. 2nd ed. Philadelphia, Balti­more, Hong Kong, London etc.: Harwal Publishing, 1994. - 337 p.
  39. 39. Mine S., Okada Y, Kawahara C, Tabata T., Tanaka Y Serum hyaluronan concentration as a marker of angi-opathy in patients with diabetes mellitus// Endocr. J. -2006. - 53,№6. -P.761-766.
  40. 40. Mishra-Gorur K., Delmolino L.M., Castellot Jr. J.J. Biological function of heparan sulfate and heparan sul­fate proteoglycans//Trends Glycosci. Glycotechnol. -1998. - l0. - P.l93-210.
  41. Nieuwdorp M., Holleman F., de Groot E., Vink H., Gort J., Kontush A., Chapman M.J., Hutten B.A. Per­turbation of hyaluronan metabolism predisposes pa­tients with type 1 diabetes mellitus to atherosclerosis/ /Diabetologia. - 2007. - 50, №6. - P.I288-1293.
  42. Nieuwdorp M., Meuwese M.C., Mooij H.L. van Lie-shout M.H., Hayden A., Levi M., Meiers J.C., Ince C, Kastelein J.J. Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endot­helial glycocalyx perturbation//Atherosclerosis. - 2009. -202,№1. - P.296-303.
  43. Nishimura M., Ookawara T., Eguchi H., Fujiwara N., Yoshihara D., Yasuda D., Mimura O., Suzuki K. Inhibition of gene expression of heparin binding epi­dermal growth factor-like growth factor by extracellu­lar superoxide dismutase in rat aortic smooth muscle cells// Free Radic. Res. - 2006. - 40, №6. - P.589-595.
  44. Potter D.R., Damiano E.R. The hydrodynamically relevant endothelial cell glycocalyx observed in vivo is absent in vitro// Circulat. Res. - 2008. - 102, №7. - P.747-748.
  45. Qui G., Hill J.S. Endothelial lipase promotes apolipoprotein AI-mediated cholesterol efflux in THP-1 macrophages//Arterioscler. Thromb. Vasc. Biol. -2009. - 29,№1. - P.84-91.
  46. Ranjbaran H., Wang У., Manes T.D., Yakimov A.O., Akhtar S., Kluger M.S., Pober J.S., Tellides G. Hep­arin displaces interferon-gamma-inducible chemokines (IP-I0, I-TAC, and Mig) sequestered in the vascula­ture and inhibits the transendothelial migration and arterial recruitment of T cells//Circulation. - 2006. -114,№12. -P.1293-1300.
  47. Ross. R. Atherosclerosis - an inflammatory disease// N. Engl. J. Med. - 1999. - 340. - P.115-126.
  48. Sakr S.W., Potter-Perigo S., Kinsella M.G., Johnson P.Y, Braun K.R., Goueffic Y, Rosenfeld M.E., Wight T.N. Hyaluronan accumulation is elevated in cultures of low density lipoprotein receptor-deficient cells and is altered by manipulation of cell cholesterol content// J. Biol. Chem. - 2008. - 283, №52. - P.36195-36204.
  49. 49. Seike M., Ikeda M., Matsumoto M., Hamada R., Takeya M., Kodama H. Hyaluronan forms complexes with low density lipoprotein while also inducing foam cell infiltration in the dermis// J. Dermatol. Sci. - 2006. -41,№3. - P.197-204.
  50. 50. Slevin M., Krupinski J., Gaffney J., Matou S., West D., Delisser H., Savani R.C, Kumar S. Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways// Matrix Biol. - 2007. - 26, № l. - P.58-68.
  51. Stoll G., Bendszus M. Inflammation and atherosclero­sis: novel insights into plaque formation and destabi-lzation//Stroke. - 2006. - 37, №7. - P.1923-1932.
  52. Tabata Т., Mine S., Okada Y, Tanaka Y Low molecular weight hyaluronan increases the uptaking of oxidized LDL into monocytes// Endocr. J. - 2007. - 54, №5. -P.685-693.
  53. Tasaki H., Yamashita K., Tsutsui M., Kamezaki F., Kubara T., Tanaka S., Sasaguri Y, Adachi T., Nakashima Y Heparin-released extracellular superoxide dismutase is reduced in patients with coronary artery athero­sclerosis// Atherosclerosis. - 2006. - 187, №1. - P.131-138.
  54. Theocharis A.D., Tsolakis I., Tzanakakis G.N., Kara-manos N.K. Chondroitin sulfate as a key molecule in the development of atherosclerosis and cancer progres­sion// Adv. Pharmacol. - 2006. - 53. - P.281-295.
  55. Tollefsen D.M. Heparin cofactor II modulates the response to vascular injury// Arterioscler. Thromb. Vasc. Biol. - 2007. - 27, №3. - P.454-460.
  56. Tovar A.M., Pecly I.M., Rangel E.P., Melo-Filho N.M., Mourro P.A., Leite M. Jr. Experimentally in­duced metabolic acidosis in rabbits modulates the in­teraction of aortic glycosaminoglycan with plasma low-density lipoprotein - an interesting observation about the association of acidosis and atherosclerosis// Ath­erosclerosis. - 2007. - 192, № 1. - P.33-39.
  57. Vicente C.P., He L., Tollefsen D.M. Accelerated athero-genesis and neointima formation in heparin cofactor II deficient mice//Blood. - 2007. - 110, №13. -P.4261-4267.
  58. Vigetti D., Viola M., Karousou E., Rizzi M., Moretto P., Genasetti A., Clerici M., Hascall V.C., De Luca G., Passi A. Hyaluronan-CD44-ERKl/2 regulate human aortic smooth muscle cell motility during aging//J. Biol. Chem. - 2008. - 283, № 7. - P.4448-4458.
  59. 59. Wong K.S., Chen C, Ng P.W., Tsoi T.H., Li H.L., Fong W.C. Low-molecular-weight heparin compared with as­pirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomized study//Lancet Neurol. - 2007. - 6, №5. - P.407-413.
  60. 60. Yao Y, Rabodzey A., Dewey C.F. Jr. Glycocalyx modu­lates the motility and proliferative response of vascular endothelium to f1uid shear stress// Amer. J. Physiol, Heart Circ.Physiol. - 2007. - 293. - №2. - P.H1023-1030.
  61. Zhao L., Lee E., Zukas A.M., Middleton M.K., Kinder M., Acharya P.S., Hall J.A., Rader D.J., Purи E. CD44 expressed on both bone marrow-derived and non-bone marrow-derived cells promotes atherogenesis in ApoE-deficient mice// Arterioscler. Thromb. Vasc. Biol. -2008. - 28. -№7. - P.1283-1289.

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2019.